China macro

The China data remains terrible, mostly due to lockdowns that have now spread to Beijing.


Commodity bulls will point to the above (noting that China is ~50% of all incremental commodity demand) and suggest something like well if prices are THIS high, given such a large demand shock, than the supply shock MUST be that much worse/larger/higher than we previously thought.

And hence they remain bullish. And indeed, as you can see below, those commodity prices are very elevated.

In our view, commodity prices are high due a mix of factors that will eventually normalise, including lingering pandemic effects.

On the supply side COVID absenteeism (caring for others, or sick themselves, or precautionary distancing) makes keeping production volumes up challenging, and on the demand side, things that can be safely consumed at a distance (which is mostly goods, as opposed to services) are the primary culprits.

The common macroeconomic component, a function of easy monetary and fiscal policy do the rest.

With COVID impacts eventually set to fade, and monetary and fiscal policy stances shifting firmly to contractionary, we think the last pillars of support to higher commodity prices will weaken.

China’s recent set of announcements to stimulate the economy do work against the views outlined above, but we would argue that stimulatory policy if commodity prices were low, would make for an attractive backdrop. But stimulatory policy that occurs because of material widespread weakness, at a time of very high prices simply makes the whole story too risky for our appetites.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.